Neuberg Ehrlich Laboratory Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 04-07-2024
- Paid Up Capital ₹ 3.18 M
as on 04-07-2024
- Company Age 45 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 53.26 Cr
as on 04-07-2024
- Revenue -15.15%
(FY 2023)
- Profit -126.58%
(FY 2023)
- Ebitda -102.06%
(FY 2023)
- Net Worth -12.89%
(FY 2023)
- Total Assets 45.02%
(FY 2023)
About Neuberg Ehrlich Laboratory
The Corporate was formerly known as Ehrlich Laboratory Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.18 M.
The company currently has active open charges totaling ₹53.26 Cr.
Subha Velu, Gomathy Kulandaivelu, Selvaraj Manivannan, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85195TN1979PTC007745
- Company No.
007745
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Mar 1979
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Saidapet, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Neuberg Ehrlich Laboratory?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subha Velu  | Nominee Director | 28-Oct-2019 | Current |
| Gomathy Kulandaivelu | Director | 04-Dec-2017 | Current |
| Selvaraj Manivannan | Nominee Director | 01-Oct-2018 | Current |
| Athmanathan Ganesan | Director | 04-Dec-2017 | Current |
| Sandhya Subramanyam | Director | 16-Sep-2010 | Current |
Financial Performance of Neuberg Ehrlich Laboratory.
Neuberg Ehrlich Laboratory Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.15% decrease. The company also saw a substantial fall in profitability, with a 126.58% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neuberg Ehrlich Laboratory?
In 2023, Neuberg Ehrlich Laboratory had a promoter holding of 100.00%. The company had 2 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Neuberg Abha Laboratory Private LimitedActive 4 years 7 monthsGomathy Kulandaivelu and Athmanathan Ganesan are mutual person
Magnum Imaging & Diagnostics Private LimitedActive 11 years 2 monthsSubha Velu and Athmanathan Ganesan are mutual person
Hamsa Medical Services Private LimitedActive 5 years 5 monthsSelvaraj Manivannan is a mutual person
Stakeboat Ventures LlpActive 4 years 5 monthsGomathy Kulandaivelu and Athmanathan Ganesan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Standard Chartered Bank Creation Date: 28 Jul 2023 | ₹16.29 Cr | Open |
Hdfc Bank Limited Creation Date: 28 Jul 2023 | ₹12.00 Cr | Open |
Hdfc Bank Limited Creation Date: 28 Jul 2023 | ₹12.00 Cr | Open |
How Many Employees Work at Neuberg Ehrlich Laboratory?
Neuberg Ehrlich Laboratory has a workforce of 560 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neuberg Ehrlich Laboratory, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neuberg Ehrlich Laboratory's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
